Polymorphisms in Toll-like receptor genes influence antibody responses to cytomegalovirus glycoprotein B vaccine

<p>Abstract</p> <p>Background</p> <p>Congenital Cytomegalovirus (CMV) infection is an important medical problem that has yet no current solution. A clinical trial of CMV glycoprotein B (gB) vaccine in young women showed promising efficacy. Improved understanding of the...

Full description

Bibliographic Details
Main Authors: Arav-Boger Ravit, Wojcik Genevieve L, Duggal Priya, Ingersoll Roxann G, Beaty Terri, Pass Robert F, Yolken Robert H
Format: Article
Language:English
Published: BMC 2012-03-01
Series:BMC Research Notes
Subjects:
Online Access:http://www.biomedcentral.com/1756-0500/5/140